Vincent Martin Selected Research

Vincent Martin Research Topics

Disease

14	Migraine Disorders (Migraine) 06/2022 - 04/2003
7	Pain (Aches) 11/2022 - 10/2004
5	Headache (Headaches) 12/2018 - 04/2003
4	Fatigue 01/2020 - 11/2009
3	Neoplasms (Cancer) 01/2019 - 10/2013
2	Inflammation (Inflammations) 05/2022 - 02/2011
1	Muscle Spasticity (Spastic) 06/2022
1	Dysbiosis 05/2022
1	Crohn Disease (Crohn's Disease) 05/2022
1	Obesity 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Insulin Resistance 01/2022
1	Overweight 01/2022
1	Sarcopenia 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020
1	Myocarditis (Carditis) 01/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019
1	Headache Disorders (Headache Syndromes) 12/2018
1	Dystonia (Limb Dystonia) 01/2018
1	Memory Disorders (Memory Loss) 01/2017
1	Cognitive Dysfunction 01/2017
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Muscular Atrophy (Muscle Atrophy) 01/2013
1	Dizziness (Lightheadedness) 04/2011
1	Sleepiness 04/2011
1	Tremor (Tremors) 04/2011
1	Nausea 04/2011
1	Dysmenorrhea (Menstrual Pain) 05/2010
1	Shock 04/2008
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 04/2008
1	Raynaud Disease (Raynaud's Disease) 04/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2004
1	Ischemia 05/2004

Drug/Important Bio-Agent (IBA)

5	Tryptamines (Triptans)IBA 09/2020 - 05/2004
3	Botulinum Toxins (Botulinum Toxin)IBA 06/2022 - 01/2018
3	TabletsIBA 06/2021 - 02/2008
3	rizatriptan (Maxalt)FDA Link 02/2008 - 10/2004
2	incobotulinumtoxinA FDA Link 11/2022 - 01/2022
2	eptinezumabIBA 06/2022 - 01/2022
2	LipidsIBA 05/2022 - 01/2022
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 09/2020
2	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 01/2019
2	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 09/2020 - 04/2011
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 01/2017
2	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2017
2	pepstatin (pepstatin A)IBA 02/2016 - 10/2013
2	JMV4463IBA 02/2016 - 10/2013
1	Type A Botulinum Toxins (Botox)FDA Link 11/2022
1	Lipocalin-2IBA 05/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2022
1	CalciumIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ErgotaminesIBA 09/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020
1	galcanezumabIBA 01/2020
1	Calcitonin Gene-Related PeptideIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Serotonin ReceptorsIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2019
1	CarcinogensIBA 01/2019
1	GlucocorticoidsIBA 01/2019
1	CytokinesIBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	agomelatine (S20098)IBA 01/2017
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 02/2016
1	statineIBA 02/2016
1	Aspartic Acid ProteasesIBA 10/2013
1	Cathepsin DIBA 10/2013
1	DipeptidesIBA 10/2013
1	Whey ProteinsIBA 01/2013
1	Caseins (Casein)FDA Link 01/2013
1	Therapeutic UsesIBA 04/2012
1	Testosterone (Sustanon)FDA Link 04/2012
1	Ibuprofen (Motrin)FDA LinkGeneric 04/2011
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2011
1	telcagepantIBA 04/2011
1	C-Reactive ProteinIBA 02/2011
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2011
1	MyoglobinIBA 02/2011
1	Sumatriptan (Imigran)FDA LinkGeneric 05/2010
1	Naproxen (Naprosyn)FDA LinkGeneric 05/2010
1	ProstaglandinsIBA 05/2010
1	Potassium Chloride FDA LinkGeneric 11/2009
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2009
1	Glucose (Dextrose)FDA LinkGeneric 04/2008
1	Pain-FreeIBA 10/2004

Therapy/Procedure

7	Therapeutics 06/2021 - 04/2003
2	Treatment Delay 06/2006 - 05/2005
1	Intravenous Infusions 01/2022
1	Resistance Training 01/2022
1	High-Protein Diet 01/2021
1	Polypharmacy 12/2018
1	Transcranial Magnetic Stimulation 06/2014
1	Injections 11/2009
1	Aftercare (After-Treatment) 05/2005